CIK 0001359931
- Non-accelerated filer
- Smaller reporting company
Protara Therapeutics, Inc.
Sign in to watch- Ticker
- TARA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 204580525
- Phone
- +1 646-844-0337
- Business address
- 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
- Former names
- Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-08 | Solomon Michael Edward Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2022-06-08 | SARGEN GREGORY Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2022-06-08 | GARCEAU ROGER Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2022-06-08 | Smith Cynthia Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2022-06-08 | BESHAR LUKE M Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2022-04-08 | Opaleye Management Inc. 10% owner | Purchase | +5,322 | $4.80 | $26K | 2,556,667 |
| 2022-04-08 | Opaleye Management Inc. 10% owner | Purchase | +2,469 | $4.80 | $12K | 127,500 |
| 2022-04-08 | Opaleye Management Inc. 10% owner | Purchase | +5,322 | $4.80 | $26K | 2,556,667 |
| 2022-04-08 | Opaleye Management Inc. 10% owner | Purchase | +2,469 | $4.80 | $12K | 127.5 |
| 2022-04-07 | Opaleye Management Inc. 10% owner | Purchase | +1,345 | $4.74 | $6K | 2,551,345 |
| 2022-04-07 | Opaleye Management Inc. 10% owner | Purchase | +1,000 | $4.74 | $5K | 125,031 |
| 2022-04-07 | Opaleye Management Inc. 10% owner | Purchase | +1,345 | $4.74 | $6K | 2,551,345 |
| 2022-04-07 | Opaleye Management Inc. 10% owner | Purchase | +1,000 | $4.74 | $5K | 125,031 |
| 2022-03-14 | BESHAR LUKE M Director | Purchase | +10,000 | $4.25 | $43K | 188,000 |
| 2022-03-10 | BESHAR LUKE M Director | Purchase | +10,000 | $4.46 | $45K | 178,000 |
| 2022-01-28 | Opaleye Management Inc. 10% owner | Purchase | +20,000 | $4.96 | $99K | 2,550,000 |
| 2022-01-28 | Opaleye Management Inc. 10% owner | Purchase | +4,031 | $4.96 | $20K | 124,031 |
| 2022-01-10 | Zummo Jacqueline Chf Scientific Operations Off | Shares withheld for taxes | −4,603 | $6.27 | $29K | 78,957 |
| 2022-01-10 | Shefferman Jesse CEO and President | Shares withheld for taxes | −5,080 | $6.27 | $32K | 872,425 |
| 2022-01-10 | Bandari Jathin Chief Medical Officer | Grant or award | +13,500 | 13,500 |
Page 10 of 17 · 335 trades